Xpert BCR-ABL Monitor Assay for the GeneXpert System CML genetic marker assay The Xpert BCR-ABL monitor from Cepheid, Sunnyvale, Calif, can be used by hematologist-oncologists and laboratorians as an aid in the monitoring of BCR-ABL, an
Read MoreCombiMatrix Corp, Mukilteo, Wash, and Clarient, Inc, Aliso Viejo, Calif, have partnered for HemeScan, a genomics-based cancer test for the treatment and care of chronic lymphocytic leukemia, and other cancers.
Read MoreThe FDA has approved the fully automated HTLV-I/HTLV-II blood-screening test from Abbott, Abbott Park, Ill, for use on the companys Prism instrument.
Read MoreGenzyme Genetics, Cambridge, Mass, a nationwide provider of genetic testing and counseling services for physicians and patients, plans to participate in a multi-center Cancer and Leukemia Group B study that will include 1,700 newly diagnosed patients with chronic lymphocytic leukemia.
Read MoreProgenika, Inc, Boston, Mass, has introduced a new genetic blood test that reduces the risk of transfusion mismatches, which cause complications for thousands of people annually.
Read More